Value Creation in the Early Phase
Summary: Venture capital and co-development partners are raising expectations prior to committing funding, and with many virtual and emerging pharma companies depending on a single lead candidate for success, it is more important than ever to make that candidate as attractive as possible. The risk to small companies of putting all their eggs in one basket can be high considering limitations on resources, funding, and broad expertise needed to advance candidates through clinical trials. What strategies can be used to help these companies succeed in both advancing their candidates and attracting investors?